Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection

References

• AthertonJCPeekRMThamKTCoverTLBlaserMJClinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pyloriGastroenterology19971121 92 998978347
   PubMed Web of Science ®Google Scholar
• LoganRPHBergDEGenetic diversity of Helicobacter pyloriLancet19963489040 1462 14638942769
   PubMed Web of Science ®Google Scholar
• AndoTMinamiMIshiguroKChanges in biochemical parameters related to atherosclerosis after Helicobacter pylori eradicationAliment Pharmacol Ther200624s4 58 64
   Google Scholar
• KanbayMGurGYucelMYlmazUBoyaciogluSDoes eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels?Dig Dis Sci200557 1228 1231
   Web of Science ®Google Scholar
• GoodmanKJCorreaPThe transmission of Helicobacter pylori: a critical review of the evidenceInt J Epidemiol1995245 875 8778557443
   PubMed Web of Science ®Google Scholar
• EusebiLHZagariRMBazzoliFEpidemiology of Helicobacter pylori infectionHelicobacter201419Suppl 1 1 5
   PubMed Web of Science ®Google Scholar
• FordACAxonATEpidemiology of Helicobacter pylori and public health implicationHelicobacter2010151 1 6
   Web of Science ®Google Scholar
• GohKLChanWKShiotaSYamaokaYEpidemiology of Helicobacter pylori infection and public health implicationHelicobacter2011161 1 9
   Web of Science ®Google Scholar
• EverhartJERecent developments in the epidemiology of Helicobacter pyloriGastroenterol Clin North Am2000293 559 57811030073
   PubMed Web of Science ®Google Scholar
• DaneshJEstimating the contribution of Helicobacter pylori to gastric cancerBr J cancer2000837 970 200010970705
   PubMed Web of Science ®Google Scholar
• BisselliRFortiniMMatricardiPMStroffoliniTD’AmelioRIncidence of Helicobacter pylori infection in a cohort of Italian military studentsInfection1999273 187 19110378130
   PubMed Web of Science ®Google Scholar
• FarkheriHBariZArabiMMalekzadehRHelicobacter pylori eradication in west Asia: a reviewWorld J Gastroenterol20142030 10355 1036725132752
   PubMed Web of Science ®Google Scholar
• YangTLiHChenJEpidemiological study on antibiotics resistance among Helicobacter pylori in Taizhou District. Zhejiang, 2010–2013Zhonghua Liu Xing Bing Xue Za Zhi2014356 704 70725174476
   PubMedGoogle Scholar
• OderdaGMariettiMPellicanoRDiagnosis and treatment of Helicobacter pylori infection in pediatrics: recommendation for 2014 clinical practiceMinerva Pediatr2015676 517 52426530493
   PubMed Web of Science ®Google Scholar
• GrahamDYFishbachLHelicobacter pylori treatment in the era of increasing antibiotic resistanceGut2010598 1143 115320525969
   PubMed Web of Science ®Google Scholar
• LooVgFalloneCADe SouzaELavalléeJBarkunANIn-vitro susceptibility of Helicobacter pylori to ampicillin, chlarithromycin, metronidazole and omeprazoleJ Antimicrobial Chemother1997406 881 883
   Web of Science ®Google Scholar
• CheungJMorseALGoodmanKJM1058 Prevalence of Helicobacter pylori and antibiotic resistance in an aboriginal population in Canada’s Arctic: preliminary results from the Aklavik H.pylori ProjectGastrenterology20091365 A341
   Web of Science ®Google Scholar
• YangJCLinCJWangHLHigh dose dual therapy is superior to standard first line or rescue therapy for Helicobacter pylori infectionClin Gastronterol Hepatol2015135 895 905
   PubMed Web of Science ®Google Scholar
• van ZantenSVDesaiSBestLRescue therapy using a rifabutin based regimen is effective for cure of Helicobacter pylori infectionCan J Gastroenterol2010245 303 30620485704
   PubMed Web of Science ®Google Scholar
• LeeJYKimNKimMSFactors affecting first-line triple therapy of Helicobacter pylori, including CYP2C19 genotype and antibiotic resistanceDig Dis Sci20145596 1235 1243
   Web of Science ®Google Scholar
• de la ObraPAlarconTDomingoDGarciaJLopez-BreaMHeteroresistance to metronidazole and genetic relationship of Helicobacter pylori clinical isolatesGut2001494 A4
   Google Scholar
• YanWHChenJHuHJYuJDHuangXLLiZYPreliminary study on “in vitro” induction of antibiotic resistance in Helicobacter pylori strains isolated from childrenZhonghua Er Ke Za Zhi2007459 708 71118021568
   PubMedGoogle Scholar
• ThungIAraminHVavinskayaVReview article: the global emergence of Helicobacter pylori antibiotic resistanceAliment Pharmacol Ther2016434 514 53326694080
   PubMed Web of Science ®Google Scholar
• GerritsMMvan der WoudenEJBaxDARole of the rdxA and frxA genes in oxygen dependent metronidazole resistance of Helicobacter pyloriJ Med Microbiol20045311 1123 112815496391
   PubMed Web of Science ®Google Scholar
• LiLKeYYuCAntibiotic resistance of Helicobacter pylori in Chinese children: a multicenter retrospective study over 7 yearsHelicobacter Epub2017118
   Web of Science ®Google Scholar
• BouihatNBurucoaCBenkiraneAHelicobacter pylori primary antibiotic resistance in 2015 in Morocco: a phenotypic and genotypic prospective and multicenter studyMicrob Drug Resist Epub20161220
   Web of Science ®Google Scholar
• ShiotaSReddyRAlsarrajAEl-SeragHBGrahamDYAntibiotic resistance of Helicobacter pylori among male United States veteransClin Gastroenterol Hepatol201513 1616 162425681693
   PubMed Web of Science ®Google Scholar
• Di GiulioMDi CampliEDi BartolomeoSIn vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in central ItalyScand J Gastroenterol2016513 263 26926554617
   PubMed Web of Science ®Google Scholar
• PilottoARassuMLeandroGFranceschiMDi MarioFInterdisciplinary Group for the Study of UlcerPrevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the study of ulcerDig Liver Dis2000329 763 76811215555
   PubMedGoogle Scholar
• TorresJCamorlinga-PonceMPerez-PerezGIncreasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in MexicoJ Clin Microbiol2001397 2677 268011427594
   PubMed Web of Science ®Google Scholar
• KatoMYamaokaYKimJJRegional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from JapanAntimicrob Agents Chemother200044 2214 221610898707
   PubMed Web of Science ®Google Scholar
• FalloneCAEpidemiology of the antibiotic resistance of Helicobacter pylori in CanadaCan J Gastroenterol20001410 879 88211111111
   PubMed Web of Science ®Google Scholar
• Perez AldanaLKatoMNakagawaSThe relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistanceHelicobacter200275 306 30912390210
   PubMed Web of Science ®Google Scholar
• MegraudFH. pylori antibiotic resistance: prevalence, importance, and advances in testingGut2004539 1374 138415306603
   PubMed Web of Science ®Google Scholar
• StorskrubbTAroPRonkainenJAntimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish populationHelicobacter2006114 224 23016882324
   PubMed Web of Science ®Google Scholar
• HorikiNOmataFUemuraMAnnual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in JapanHelicobacter2009145 86 9019751432
   PubMed Web of Science ®Google Scholar
• GaoWChengHHuFThe evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, ChinaHelicobacter2010155 460 46621083752
   PubMed Web of Science ®Google Scholar
• ZhangYXZhouLYSongZQZhangJZHeLHDingYPrimary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial studyWorld J Gastroenterol2015219 2786 279225759550
   PubMed Web of Science ®Google Scholar
• De FrancescoVGiorgioFHassanCWorldwide H. pylori antibiotic resistance: a systematic reviewJ Gastrointestin Liver Dis2010194 409 41421188333
   PubMed Web of Science ®Google Scholar
• KimJJReddyRLeeMAnalysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from KoreaJ Antimicrob Chemother2001474 459 46111266421
   PubMed Web of Science ®Google Scholar
• MituiMPatelALeosNKDoernCDParkJYNovel Helicobacter pylori sequencing test identifies high rate of clarithromycin resistanceJ Pediatr Gastroenterol Nutr2014591 6 925222804
   PubMed Web of Science ®Google Scholar
• QureshiNNGallaherBSchillerNLEvolution of amoxicillin resistance of Helicobacter pylori in vitro: characterization of resistance mechanismsMicrob Drug Resist2014206 509 51624901497
   PubMed Web of Science ®Google Scholar
• Debets-OssenkoppYJHerscheidAJPotRGKuipersEJKustersJGVandenbroucke-GraulsCMPrevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The NetherlandsJ Antimicrob Chemother1999434 511 51510350380
   PubMed Web of Science ®Google Scholar
• SelgradMTammerILangnerCDifferent antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infectionWorld J Gastroenterol201420 16245 1625125473179
   PubMed Web of Science ®Google Scholar
• YoonKHParkSWLeeSWKimBJKimJGClarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the KoreaJ Korean Med Sci2014299 1240 124625246742
   PubMed Web of Science ®Google Scholar
• GodoyAPRibeiroMLBenvengoYHAnalysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolatesBMC Gastroenterol20033 2012911839
   PubMed Web of Science ®Google Scholar
• GerritsMMde ZoeteMRArentsNLKuipersEJKustersJG16S rRNA mutation-mediated tetracycline resistance in Helicobacter pyloriAntimicrob Agents Chemother2002469 2996 300012183259
   PubMed Web of Science ®Google Scholar
• MegraudFCoenenSVersportenAHelicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumptionGut2013621 34 4222580412
   PubMed Web of Science ®Google Scholar
• Cuch BurgosEFornè BarderaMQuintana RieraSLite LiteJGarau AlemanyJEvolution of the sensitivity of 235 strains of Helicobacter pylori from 1995 to 1998 and impact of antibiotic treatmentEnferm Infecc Microbiol Clin2002204 157 16011996701
   PubMed Web of Science ®Google Scholar
• CattoirVNectouxJLascolsCUpdate on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibilityInt J Antimicrob Agents200729 389 39617303392
   PubMed Web of Science ®Google Scholar
• SaracinoIMZulloAHoltonJHigh prevalence of primary antibiotic resistance in Helicobacter pylori isolates in ItalyJ Gastrointestin Liver Dis2012214 363 36523256118
   PubMed Web of Science ®Google Scholar
• CabritaJOleastroMMatosRFeatures and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990–1999)J Antimicrob Chemother2000466 1029 103111102427
   PubMed Web of Science ®Google Scholar
• ChangWLSheuBSChengHCYangYJYangHBWuJJResistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in TaiwanJ Gastroenterol Hepatol2009247 1230 123519476562
   PubMed Web of Science ®Google Scholar
• Cuadrado-LavinASalcines-CaviedesJRCarrascosaMFAntimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in SpainJ Antimicrob Chemother2011671 170 17321965436
   PubMed Web of Science ®Google Scholar
• KimNKimJMKimCHInstitutional difference of antibiotic resistance of Helicobacter pylori strains in KoreaJ Clin Gastroenterol2006408 683 68716940878
   PubMed Web of Science ®Google Scholar
• BiernatMMPoniewierkaEBlaszcukJAntimicrobial susceptibility of Helicobacter pylori isolates from lower Silesia, PolandArch Med Sci2014103 505 50925097581
   PubMed Web of Science ®Google Scholar
• MascellinoMTOlivaADe AngelisMPorowskaBHelicobacter pylori infection: susceptibility to antimicrobials and eradication rate in pluri treated pangastritis patientsIndian J Appl Res201554 30 32
   Google Scholar
• AmitranoMSpezzaferroMSaccoFM1087 H. pylori isolates from proximal and distal stomach of patients with H. pylori infection exhibit resistance and sensitivity to the same antibioticGastroenterology20081344 A335
   Web of Science ®Google Scholar
• IkezawaKKashimuraHKojimaMPretreatment antimicrobial susceptibilities of paired gastric Helicobacter pylori isolates: antrum versus corpusHelicobacter199944 218 22110597389
   PubMed Web of Science ®Google Scholar
• MatteoMJGranadosGOlmosMWonogaACatalanoMHelicobacter pylori amoxicillin heteroresistance due to point mutation in PBP-1A in esogenic isolatesJ Antimicrob Chemoter2008613 474 477
   Web of Science ®Google Scholar
• Ben MansourKFendriCBattikhHMultiple and mixed Helicobacter pylori infections: comparison of two epidemiological situations in Tunisia and FranceInfect Genet Evol201637 43 4826518911
   PubMed Web of Science ®Google Scholar
• RaymondJLamarqueDKalachNChaussadeSBurucoaCHigh level of antimicrobial resistance in French Helicobacter pylori isolatesHelicobacter2010151 21 27
   PubMed Web of Science ®Google Scholar
• GarciaMRaymondJGarnierMCremniterJBurucoaCDistribution of spontaneous gyrA mutations in 97 fluoroquinolone-resistant Helicobacter pylori isolates collected in FranceAntimicrob Agents Chemother2012561 550 55122064536
   PubMed Web of Science ®Google Scholar
• KaoCYLeeAYHuangAHHeteroresistance of Helicobacter pylori from the same patient prior to antibiotic treatmentInfect Genet Evol201423 196 20224576534
   PubMed Web of Science ®Google Scholar
• OleastroMMenardASantosAReal-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pyloriJ Clin Microbiol2003411 397 40212517879
   PubMed Web of Science ®Google Scholar
• KimJJKimJGKnownDHMixed-infection of antibiotics susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testingHelicobacter200383 202 20612752732
   PubMed Web of Science ®Google Scholar
• MascellinoMTPorowskaBNicosiaROlivaABocciaPSeveriCImpact of Helicobacter pylori in unsuccessfully pluritreated patients in a department of infectious disease in RomeMicrobiol Res20102 9 14
   Google Scholar
• Van der EndeAvan DoornLJRooijakkersSFellerMTytgatGNJDankertJClarithromycin-susceptible and –resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapyJ Clin Microbiol2001397 2648 265111427586
   PubMed Web of Science ®Google Scholar
• NorazahARasinahWZZailiZAminuddinARamelahMAnalysis of PCR-Rapid DNA and antibiotic susceptibility profiles of antrum and corpus of the same isolates of Helicobacter pylori from Malaysian patientsMalays J Pathol2009311 29 3419694311
   PubMedGoogle Scholar
• GlockerEBerningMGerritsMMKustersJGKistMReal time PCR screening for 16 S rRna mutations associated with resistance to tetracycline in Helicobacter pyloriAntimicrob Agents Chemoter2005498 3166 3170
   Web of Science ®Google Scholar
• HeepMKistMStrobelSBeckDLehnNSecondary resistance among 554 isolates of Helicobacter pylori after failure of therapyEur J Clin Microbiol Infect Dis2000197 538 54110968325
   PubMed Web of Science ®Google Scholar
• ChisholmSAOwenRJTeareELSaverymuttuSPCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samplesJ Clin Microbiol2001394 1217 122011283030
   PubMed Web of Science ®Google Scholar
• LiouJMChenCCChangCYEfficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trialJ Antimicrob Chemother2013682 450 45623099849
   PubMed Web of Science ®Google Scholar
• Schabereiter-GurtnerCHirschlAMDragosicsBNovel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimensJ Clin Microbiol200442 4512 451815472302
   PubMed Web of Science ®Google Scholar
• MiwaHNagaharaAKurosawaAIs antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?Aliment Pharmacol Ther20031712 1545 155112823158
   PubMed Web of Science ®Google Scholar
• WenzhenYYuminLQuanlinGIs antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta – analysis of randomized controlled trialsIntern Med20104912 1103 110920558925
   PubMed Web of Science ®Google Scholar
• GomollonFSiciliaBDucónsJASierraERevilloMJFerreroMThird line treatment for Helicobacter pylori: a prospective, cultured-guided study in peptic ulcer patientsAliment Pharmacol Ther20001410 1335 133811012479
   PubMed Web of Science ®Google Scholar
• GrahamDYEditorial: avoiding unethical Helicobacter pylori clinical trials: susceptibility-based studies and probiotics as adjuvantsHelicobacter2015205 321 32526123529
   PubMed Web of Science ®Google Scholar
• ZulloAHassanCLorenzettiRWinnSMoriniSA clinical practice viewpoint: to culture or not to culture Helicobacter pylori?Dig Liver Dis2003355 357 36112846409
   PubMedGoogle Scholar
• WuJYLiouJMGrahamDYEvidence based recommendations for successful Helicobacter pylori treatmentExpert Rev Gastroenterol Hepatol201481 21 2824410470
   PubMed Web of Science ®Google Scholar
• JenksPJCauses of failure of eradication of Helicobacter pylori. Antibiotic resistance is the major cause and susceptibility testing may helpBMJ20023257354 3 412098709
   PubMed Web of Science ®Google Scholar
• DixonMFGentaRMYardleyJHCorreaPClassification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994Am J Surg Pathol19962010 1161 11818827022
   PubMed Web of Science ®Google Scholar
• GisbertJPGonzalezLCalvetXProton pump inhibitor, clarithromycin and either amoxicillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pyloriAliment Pharmacol Ther20001410 1319 132811012477
   PubMed Web of Science ®Google Scholar
• FalloneCAChibaNvan ZantenSVThe Toronto consensus for treatment of Helicobacter pylori infection in adultsGastroenterology20161511 51 6927102658
   PubMed Web of Science ®Google Scholar
• LaineLHuntREl-ZimaityHNguyenBOsatoMSpénardJBismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: randomized, multicenter North American trialAm J Gastroenterol2003983 562 56712650788
   PubMed Web of Science ®Google Scholar
• VeneritoMKriegerTEcherTLeandroGMalfertheinerPMeta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infectionDigestion2013881 33 4523880479
   PubMed Web of Science ®Google Scholar
• MatsumotoHShiotaniAKatsumataRHelicobacter pylori eradication with proton pump inhibitors or potassium-competitive acid blockers: the effect of clarithromycin resistanceDig Dis Sci20166111 3215 322027659671
   PubMed Web of Science ®Google Scholar
• ZulloAGattaLDe FrancescoVHigh rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a Prospective Controlled StudyAliment Pharmacoy Ther20052112 1419 1424
   Web of Science ®Google Scholar
• WuDCHsuPIWuJYSequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infectionClin Gastroenterol Hepatol201081 36 4119804842
   PubMed Web of Science ®Google Scholar
• EssaASKramerJRGrahamDYTreiberGMeta-analysis: four-drug, three-antibiotic, non-bismuth containing “concomitant therapy” versus triple therapy for Helicobacter pylori eradicationHelicobacter2009142 109 11819298338
   PubMed Web of Science ®Google Scholar
• TursiADi MarioFFranceschiMNew bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: a first Italian experience in clinical practiceHelicobacter Epub2017126
   Web of Science ®Google Scholar
• DelchierJCMalfertheinerPThieroff-EkerdtRUse of combination formulation of bismuth,metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pyloriAliment Pharmacol Ther2014402 171 17724863854
   PubMed Web of Science ®Google Scholar
• LeeYJParkKSOptimal first-line treatment for Helicobacter pylori infection: recent strategiesGastroenterol Res Pract20162016 908658128070184
   PubMed Web of Science ®Google Scholar
• AkazawaYFukudaDFukudaYVonoprazan-based therapy for Helicobacter pylori eradication: experience and clinical evidenceTherap Adv Gastroenterol201696 845 852
   Web of Science ®Google Scholar
• MurakamiKSakuraiYShiinoMFunaoNNishimuraAAsakaMVonoprazan a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomized, double-blind studyGut2016659 1439 144626935876
   PubMed Web of Science ®Google Scholar
• SuzukiSGotodaTKusanoCIwatsukaKMoriyamaMThe efficacy and tolerability of a triple therapy containing a potassium-competitive acid blocker compared with a 7-day, PPI-based low-dose clarithromycin triple therapyAm J Gastroenterol20161117 949 95627185079
   PubMed Web of Science ®Google Scholar
• NodaHNoguchiSYoshimineTA novel potassium-competitive acid blocker improves the efficacy of clarithromycin-containing 7-day triple therapy against Helicobacter pyloriJ Gastrointestin Liver Dis2016253 283 28827689190
   PubMed Web of Science ®Google Scholar
• AyalaGEscobedo-HinojosaWIde la Cruz-HerreraCFHerreraCRomerIExploring alternative treatment for Helicobacter pylori infectionWorld J Gastroenterol2014206 1450 146924587621
   PubMed Web of Science ®Google Scholar
• RuggieroPUse of probiotics in the fight against Helicobacter pyloriWorld J Gastrointest Pathophysiol201454 384 39125400981
   PubMedGoogle Scholar
• GopalRJeongESeoCHParkYRole of antimicrobical peptides expressed by host cells upon infection by Helicobacter pyloriProtein Pept Lett20142110 1057 106425001211
   PubMed Web of Science ®Google Scholar